Home > Healthcare & Medical Devices > Molecular Diagnostics Market > Table of Contents

Molecular Diagnostics Market Size By Product (Instruments, Reagents & Kits), By Technology (Polymerase Chain Reaction [PCR], Hybridization, Sequencing, Isothermal Nucleic Acid Amplification Technology [INAAT], Microarrays), By Application (Infectious Disease Diagnostics {COVID-19, HIV, CT/NG, Hepatitis B, Hepatitis C, RSV, Flu, Tuberculosis}, Oncology Testing, Genetic Disease Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI434
  • Base Year: 2021
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Molecular diagnostics industry 360° synopsis, 2017 – 2028

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Molecular Diagnostics Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Technological advances and increasing awareness towards early disease diagnosis in North America

3.3.1.2    Escalating demand for POC diagnostics in Asia Pacific

3.3.1.3    Increasing geriatric population

3.3.1.4    Increasing number of R&D initiatives in developing economies

3.3.1.5    Rising incidences of infectious diseases

3.3.2    Industry pitfalls and challenges

3.3.2.1    Lack of clear and uniform regulatory framework

3.3.2.2    Increasing cost of disease diagnostics

3.4    COVID-19 impact analysis

3.5    Growth potential analysis

3.5.1    By product

3.5.2    By technology

3.5.3    By application

3.5.4    By end-use

3.6    Porter’s analysis

3.7    Competitive landscape, 2021

3.7.1    Company matrix analysis, 2021

3.8    PESTEL analysis

Chapter 4   Molecular Diagnostics Market, By Product

4.1    Key segment trends

4.2    Instruments

4.2.1    Market size, by region, 2017 – 2028 (USD Million)

4.3    Reagents and kits

4.3.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 5   Molecular Diagnostics Market, By Technology

5.1    Key segment trends

5.2    Polymerase chain reaction (PCR)

5.2.1    Market size, by region, 2017 – 2028 (USD Million)

5.3    Hybridization

5.3.1    Market size, by region, 2017 – 20288 (USD Million)

5.4    Sequencing

5.4.1    Market size, by region, 2017 – 2028 (USD Million)

5.5    Isothermal nucleic acid amplification technology (INAAT)

5.5.1    Market size, by region, 2017 – 2028 (USD Million)

5.6    Microarrays

5.6.1    Market size, by region, 2017 – 2028 (USD Million)

5.7    Others

5.7.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 6   Molecular Diagnostics Market, By Application

6.1    Key segment trends

6.2    Infectious disease diagnostics

6.2.1    Market size, by region, 2017 – 2028 (USD Million)

6.2.2    COVID-19

6.2.2.1    Market size, by region, 2017-2028 (USD Million)

6.2.3    HIV

6.2.3.1    Market size, by region, 2017-2028 (USD Million)

6.2.4    CT/NG

6.2.4.1    Market size, by region, 2017-2028 (USD Million)

6.2.5    Hepatitis B

6.2.5.1    Market size, by region, 2017-2028 (USD Million)

6.2.6    Hepatitis C

6.2.6.1    Market size, by region, 2017-2028 (USD Million)

6.2.7    RSV

6.2.7.1    Market size, by region, 2017-2028 (USD Million)

6.2.8    Flu

6.2.8.1    Market size, by region, 2017-2028 (USD Million)

6.2.9    Tuberculosis

6.2.9.1    Market size, by region, 2017-2028 (USD Million)

6.2.10    Others

6.3    Oncology testing

6.3.1    Market size, by region, 2017 – 2028 (USD Million)

6.4    Genetic disease testing

6.4.1    Market size, by region, 2017 – 2028 (USD Million)

6.5    Others

6.5.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 7   Molecular Diagnostics Market, By End-use

7.1    Key segment trends

7.2    Hospitals and clinics

7.2.1    Market size, by region, 2017 – 2028 (USD Million)

7.3    Diagnostic laboratories

7.3.1    Market size, by region, 2017 – 2028 (USD Million)

7.4    Others

7.4.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 8   Molecular Diagnostics Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country 2017 – 2028 (USD Million)

8.2.2    Market size, by product, 2017 – 2028 (USD Million)

8.2.3    Market size, by technology, 2017 – 2028 (USD Million)

8.2.4    Market size, by application, 2017 – 2028 (USD Million)

8.2.4.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.2.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.2.6    U.S.

8.2.6.1    Market size, by product, 2017 – 2028 (USD Million)

8.2.6.2    Market size, by technology, 2017 – 2028 (USD Million)

8.2.6.3    Market size, by application, 2017 – 2028 (USD Million)

8.2.6.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.2.6.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.2.7    Canada

8.2.7.1    Market size, by product, 2017 – 2028 (USD Million)

8.2.7.2    Market size, by technology, 2017 – 2028 (USD Million)

8.2.7.3    Market size, by application, 2017 – 2028 (USD Million)

8.2.7.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.2.7.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.3    Europe

8.3.1    Market size, by country 2017 – 2028 (USD Million)

8.3.2    Market size, by product, 2017 – 2028 (USD Million)

8.3.3    Market size, by technology, 2017 – 2028 (USD Million)

8.3.4    Market size, by application, 2017 – 2028 (USD Million)

8.3.4.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.3.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.6    Germany

8.3.6.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.6.2    Market size, by technology, 2017 – 2028 (USD Million)

8.3.6.3    Market size, by application, 2017 – 2028 (USD Million)

8.3.6.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.3.6.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.7    France

8.3.7.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.7.2    Market size, by technology, 2017 – 2028 (USD Million)

8.3.7.3    Market size, by application, 2017 – 2028 (USD Million)

8.3.7.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.3.7.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.8    UK

8.3.8.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.8.2    Market size, by technology, 2017 – 2028 (USD Million)

8.3.8.3    Market size, by application, 2017 – 2028 (USD Million)

8.3.8.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.3.8.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.9    Italy

8.3.9.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.9.2    Market size, by technology, 2017 – 2028 (USD Million)

8.3.9.3    Market size, by application, 2017 – 2028 (USD Million)

8.3.9.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.3.9.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.10    Spain

8.3.10.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.10.2    Market size, by technology, 2017 – 2028 (USD Million)

8.3.10.3    Market size, by application, 2017 – 2028 (USD Million)

8.3.10.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.3.10.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country 2017 – 2028 (USD Million)

8.4.2    Market size, by technology, 2017 – 2028 (USD Million)

8.4.3    Market size, by application, 2017 – 2028 (USD Million)

7.2.2.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.4.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.5    China

8.4.5.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.5.2    Market size, by technology, 2017 – 2028 (USD Million)

8.4.5.3    Market size, by application, 2017 – 2028 (USD Million)

8.4.5.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.4.5.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.6    Japan

8.4.6.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.6.2    Market size, by technology, 2017 – 2028 (USD Million)

8.4.6.3    Market size, by application, 2017 – 2028 (USD Million)

8.4.6.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.4.6.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.7    India

8.4.7.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.7.2    Market size, by technology, 2017 – 2028 (USD Million)

8.4.7.3    Market size, by application, 2017 – 2028 (USD Million)

8.4.7.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.4.7.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.8    Australia

8.4.8.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.8.2    Market size, by technology, 2017 – 2028 (USD Million)

8.4.8.3    Market size, by application, 2017 – 2028 (USD Million)

8.4.8.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.4.8.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.5    Latin America

8.5.1    Market size, by country 2017 – 2028 (USD Million)

8.5.2    Market size, by product, 2017 – 2028 (USD Million)

8.5.3    Market size, by technology, 2017 – 2028 (USD Million)

8.5.4    Market size, by application, 2017 – 2028 (USD Million)

8.5.4.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.5.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.5.6    Brazil

8.5.6.1    Market size, by product, 2017 – 2028 (USD Million)

8.5.6.2    Market size, by technology, 2017 – 2028 (USD Million)

8.5.6.3    Market size, by application, 2017 – 2028 (USD Million)

8.5.6.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.5.6.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.5.7    Mexico

8.5.7.1    Market size, by product, 2017 – 2028 (USD Million)

8.5.7.2    Market size, by technology, 2017 – 2028 (USD Million)

8.5.7.3    Market size, by application, 2017 – 2028 (USD Million)

8.5.7.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.5.7.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.6    Middle East

8.6.1    Market size, by country 2017 – 2028 (USD Million)

8.6.2    Market size, by product, 2017 – 2028 (USD Million)

8.6.3    Market size, by technology, 2017 – 2028 (USD Million)

8.6.4    Market size, by application, 2017 – 2028 (USD Million)

8.6.4.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.6.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.6.6    Saudi Arabia

8.6.6.1    Market size, by product, 2017 – 2028 (USD Million)

8.6.6.2    Market size, by technology, 2017 – 2028 (USD Million)

8.6.6.3    Market size, by application, 2017 – 2028 (USD Million)

8.6.6.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.6.6.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.6.7    UAE

8.6.7.1    Market size, by product, 2017 – 2028 (USD Million)

8.6.7.2    Market size, by technology, 2017 – 2028 (USD Million)

8.6.7.3    Market size, by application, 2017 – 2028 (USD Million)

8.6.7.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.6.7.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.6.8    Israel

8.6.8.1    Market size, by product, 2017 – 2028 (USD Million)

8.6.8.2    Market size, by technology, 2017 – 2028 (USD Million)

8.6.8.3    Market size, by application, 2017 – 2028 (USD Million)

8.6.8.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.6.8.4    Market size by end-use, 2017-2018 (USD Million)

8.7    Africa

8.7.1    South Africa

8.7.1.1    Market size, by product, 2017 – 2028 (USD Million)

8.7.1.2    Market size, by technology, 2017 – 2028 (USD Million)

8.7.1.3    Market size, by application, 2017 – 2028 (USD Million)

8.7.1.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.7.1.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.7.2    Nigeria

8.7.2.1    Market size, by product, 2017 – 2028 (USD Million)

8.7.2.2    Market size, by technology, 2017 – 2028 (USD Million)

8.7.2.3    Market size, by application, 2017 – 2028 (USD Million)

8.7.2.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.7.2.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.7.3    Morocco

8.7.3.1    Market size, by product, 2017 – 2028 (USD Million)

8.7.3.2    Market size, by technology, 2017 – 2028 (USD Million)

8.7.3.3    Market size, by application, 2017 – 2028 (USD Million)

8.7.3.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.7.3.4    Market size, by end-use, 2017 – 2028 (USD Million)

8.7.4    Egypt

8.7.4.1    Market size, by product, 2017 – 2028 (USD Million)

8.7.4.2    Market size, by technology, 2017 – 2028 (USD Million)

8.7.4.3    Market size, by application, 2017 – 2028 (USD Million)

8.7.4.3.1    Market size, by infectious disease diagnostics, 2017 - 2028 (USD Million)

8.7.4.4    Market size, by end-use, 2017 – 2028 (USD Million)

Chapter 9   Company Profiles

9.1    Strategy dashboard, 2021

9.2    Abbott Laboratories

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Agilent Technologies Inc.

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    Becton, Dickinson and Company

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    Biocartis

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Biomerieux SA

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Bio-Rad Laboratories Inc.

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Danaher Corporation

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    F. Hoffmann-La Roche AG

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Hologic, Inc.

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Illumina, Inc.

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis

9.12    Qiagen

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.12.5    SWOT analysis

9.13    Quidel Corporation

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook

9.13.5    SWOT analysis

9.14    Siemens Healthineers AG

9.14.1    Business overview

9.14.2    Financial data

9.14.3    Product landscape

9.14.4    Strategic outlook

9.14.5    SWOT analysis

9.15    Sysmex Corporation

9.15.1    Business overview

9.15.2    Financial data

9.15.3    Product landscape

9.15.4    Strategic outlook

9.15.5    SWOT analysis

9.16    Thermo Fisher Scientific

9.16.1    Business overview

9.16.2    Financial data

9.16.3    Product landscape

9.16.4    Strategic outlook

9.16.5    SWOT analysis
 

Data Tables

TABLE 1.    Molecular diagnostics industry 360° synopsis, 2017 - 2028

TABLE 2.    Molecular diagnostics market, 2017 - 2028, (USD Million)

TABLE 3.    Global molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 4.    Global molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 5.    Global molecular diagnostics market, by technology, 2017 - 2021, (USD Million)

TABLE 6.    Global molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 7.    Global molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 8.    Global molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 9.    Global molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 10.    Global molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 11.    Global molecular diagnostics market by region, 2017 - 2021 (USD Million)

TABLE 12.    Global molecular diagnostics market by region, 2022 - 2028, (USD Million)

TABLE 13.    Industry impact forces

TABLE 14.    Instruments market by region, 2017 - 2021 (USD Million)

TABLE 15.    Instruments market by region, 2022 - 2028, (USD Million)

TABLE 16.    Reagents & kits market by region, 2017 - 2021 (USD Million)

TABLE 17.    Reagents & kits market by region, 2022 - 2028, (USD Million)

TABLE 18.    Polymerase chain reaction (PCR) market by region, 2017 - 2021 (USD Million)

TABLE 19.    Polymerase chain reaction (PCR) market by region, 2022 - 2028, (USD Million)

TABLE 20.    Hybridization market by region, 2017 - 2021 (USD Million)

TABLE 21.    Hybridization market by region, 2022 - 2028, (USD Million)

TABLE 22.    Sequencing market by region, 2017 - 2021 (USD Million)

TABLE 23.    Sequencing market by region, 2022 - 2028, (USD Million)

TABLE 24.    Isothermal nucleic acid amplification technology (INAAT) market by region, 2017 - 2021 (USD Million)

TABLE 25.    Isothermal nucleic acid amplification technology (INAAT) market by region, 2022 - 2028, (USD Million)

TABLE 26.    Microarrays market by region, 2017 - 2021 (USD Million)

TABLE 27.    Microarrays market by region, 2022 - 2028, (USD Million)

TABLE 28.    Others market by region, 2017 - 2021 (USD Million)

TABLE 29.    Others market by region, 2022 - 2028, (USD Million)

TABLE 30.    Infectious disease diagnostics market by region, 2017 - 2021 (USD Million)

TABLE 31.    Infectious disease diagnostics market by region, 2022 - 2028, (USD Million)

TABLE 32.    COVID-19 market by region, 2017 - 2021 (USD Million)

TABLE 33.    COVID-19 dressings market by region, 2022 - 2028, (USD Million)

TABLE 34.    HIV market by region, 2017 - 2021 (USD Million)

TABLE 35.    HIV dressings market by region, 2022 - 2028, (USD Million)

TABLE 36.    CT/NG market by region, 2017 - 2021 (USD Million)

TABLE 37.    CT/NG market by region, 2022 - 2028, (USD Million)

TABLE 38.    Hepatitis B market by region, 2017 - 2021 (USD Million)

TABLE 39.    Hepatitis B market by region, 2022 - 2028, (USD Million)

TABLE 40.    Hepatitis C market by region, 2017 - 2021 (USD Million)

TABLE 41.    Hepatitis C market by region, 2022 - 2028, (USD Million)

TABLE 42.    RSV market by region, 2017 - 2021 (USD Million)

TABLE 43.    RSV market by region, 2022 - 2028, (USD Million)

TABLE 44.    Flu market by region, 2017 - 2021 (USD Million)

TABLE 45.    Flu market by region, 2022 - 2028, (USD Million)

TABLE 46.    Tuberculosis market by region, 2017 - 2021 (USD Million)

TABLE 47.    Tuberculosis market by region, 2022 - 2028, (USD Million)

TABLE 48.    Others market by region, 2017 - 2021 (USD Million)

TABLE 49.    Others market by region, 2022 - 2028, (USD Million)

TABLE 50.    Oncology testing devices market by region, 2017 - 2021 (USD Million)

TABLE 51.    Oncology testing devices market by region, 2022 - 2028, (USD Million)

TABLE 52.    Genetic disease testing market by region, 2017 - 2021 (USD Million)

TABLE 53.    Genetic disease testing market by region, 2022 - 2028, (USD Million)

TABLE 54.    Others market by region, 2017 - 2021 (USD Million)

TABLE 55.    Others market by region, 2022 - 2028, (USD Million)

TABLE 56.    Diagnostic laboratories market by region, 2017 - 2021 (USD Million)

TABLE 57.    Diagnostic laboratories market by region, 2022 - 2028, (USD Million)

TABLE 58.    Hospitals & clinics market by region, 2017 - 2021 (USD Million)

TABLE 59.    Hospitals & clinics market by region, 2022 - 2028, (USD Million)

TABLE 60.    Others market by region, 2017 - 2021 (USD Million)

TABLE 61.    Others market by region, 2022 - 2028, (USD Million)

TABLE 62.    North America molecular diagnostics market, by country, 2017 - 2021, (USD Million)

TABLE 63.    North America molecular diagnostics market, by country, 2022 - 2028, (USD Million)

TABLE 64.    North America molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 65.    North America molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 66.    North America molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 67.    North America molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 68.    North America molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 69.    North America molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 70.    North America molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 71.    North America molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 72.    North America molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 73.    North America molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 74.    U.S. molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 75.    U.S. molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 76.    U.S. molecular diagnostics market, by technology, 2017 - 2021 (USD Million)

TABLE 77.    U.S. molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 78.    U.S. molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 79.    U.S. molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 80.    U.S. molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 81.    U.S. molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 82.    U.S. molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 83.    U.S. molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 84.    Canada molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 85.    Canada molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 86.    Canada molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 87.    Canada molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 88.    Canada molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 89.    Canada molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 90.    Canada molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 91.    Canada molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 92.    Canada molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 93.    Canada molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 94.    Europe molecular diagnostics market, by country, 2017 - 2021, (USD Million)

TABLE 95.    Europe molecular diagnostics market, by country, 2022 - 2028, (USD Million)

TABLE 96.    Europe molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 97.    Europe molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 98.    Europe molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 99.    Europe molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 100.    Europe molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 101.    Europe molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 102.    Europe molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 103.    Europe molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 104.    Europe molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 105.    Europe molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 106.    Germany molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 107.    Germany molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 108.    Germany molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 109.    Germany molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 110.    Germany molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 111.    Germany molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 112.    Germany molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 113.    Germany molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 114.    Germany molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 115.    Germany molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 116.    UK molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 117.    UK molecular diagnostics market, by product, 2017 – 2021, (USD Million)

TABLE 118.    UK molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 119.    UK molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 120.    UK molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 121.    UK molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 122.    UK molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 123.    UK molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 124.    UK molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 125.    UK molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 126.    France molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 127.    France molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 128.    France molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 129.    France molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 130.    France molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 131.    France molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 132.    France molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 133.    France molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 134.    France molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 135.    France molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 136.    Italy molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 137.    Italy molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 138.    Italy molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 139.    Italy molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 140.    Italy molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 141.    Italy molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 142.    Italy molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 143.    Italy molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 144.    Italy molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 145.    Italy molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 146.    Spain molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 147.    Spain molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 148.    Spain molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 149.    Spain molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 150.    Spain molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 151.    Spain molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 152.    Spain molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 153.    Spain molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 154.    Spain molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 155.    Spain molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 156.    Asia Pacific molecular diagnostics market, by country, 2017 - 2021, (USD Million)

TABLE 157.    Asia Pacific molecular diagnostics market, by country, 2022 - 2028, (USD Million)

TABLE 158.    Asia Pacific molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 159.    Asia Pacific molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 160.    Asia Pacific molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 161.    Asia Pacific molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 162.    Asia Pacific molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 163.    Asia Pacific molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 164.    Asia Pacific molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 165.    Asia Pacific molecular diagnostics market, by infectious disease diagnostics, 2021 – 2028 (USD Million)

TABLE 166.    Asia Pacific molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 167.    Asia Pacific molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 168.    Japan molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 169.    Japan molecular diagnostics market, by product, 2017 – 2021, (USD Million)

TABLE 170.    Japan molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 171.    Japan molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 172.    Japan molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 173.    Japan molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 174.    Japan molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 175.    Japan molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 176.    Japan molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 177.    Japan molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 178.    India molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 179.    India molecular diagnostics market, by product, 2017 – 2021, (USD Million)

TABLE 180.    India molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 181.    India molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 182.    India molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 183.    India molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 184.    India molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 185.    India molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 186.    India molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 187.    India molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 188.    China molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 189.    China molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 190.    China molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 191.    China molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 192.    China molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 193.    China molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 194.    China molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 195.    China molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 196.    China molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 197.    China molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 198.    Australia molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 199.    Australia molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 200.    Australia molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 201.    Australia molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 202.    Australia molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 203.    Australia molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 204.    Australia molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 205.    Australia molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 206.    Australia molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 207.    Australia molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 208.    Latin America molecular diagnostics market, by country, 2017 - 2021, (USD Million)

TABLE 209.    Latin America molecular diagnostics market, by country, 2022 - 2028 USD Million)

TABLE 210.    Latin America molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 211.    Latin America molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 212.    Latin America molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 213.    Latin America molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 214.    Latin America molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 215.    Latin America molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 216.    Latin America molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 217.    Latin America molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 218.    Latin America molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 219.    Latin America molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 220.    Brazil molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 221.    Brazil molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 222.    Brazil molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 223.    Brazil molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 224.    Brazil molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 225.    Brazil molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 226.    Brazil molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 227.    Brazil molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 228.    Brazil molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 229.    Brazil molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 230.    Mexico molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 231.    Mexico molecular diagnostics market, by product, 2017 – 2021, (USD Million)

TABLE 232.    Mexico molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 233.    Mexico molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 234.    Mexico molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 235.    Mexico molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 236.    Mexico molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 237.    Mexico molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 238.    Mexico molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 239.    Mexico molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 240.    Middle East molecular diagnostics market, by country, 2017 - 2021, (USD Million)

TABLE 241.    Middle East molecular diagnostics market, by country, 2022 - 2028 USD Million)

TABLE 242.    Middle East molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 243.    Middle East molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 244.    Middle East molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 245.    Middle East molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 246.    Middle East molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 247.    Middle East molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 248.    Middle East molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 249.    Middle East molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 250.    Middle East molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 251.    Middle East molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 252.    Saudi Arabia molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 253.    Saudi Arabia molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 254.    Saudi Arabia molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 255.    Saudi Arabia molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 256.    Saudi Arabia molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 257.    Saudi Arabia molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 258.    Saudi Arabia molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 259.    Saudi Arabia molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 260.    Saudi Arabia molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 261.    Saudi Arabia molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 262.    UAE molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 263.    UAE molecular diagnostics market, by product, 2017 – 2021, (USD Million)

TABLE 264.    UAE molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 265.    UAE molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 266.    UAE molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 267.    UAE molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 268.    UAE molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 269.    UAE molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 270.    UAE molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 271.    UAE molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 272.    Israel molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 273.    Israel molecular diagnostics market, by product, 2017 – 2021, (USD Million)

TABLE 274.    Israel molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 275.    Israel molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 276.    Israel molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 277.    Israel molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 278.    Israel molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 279.    Israel molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 280.    Israel molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 281.    Israel molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 282.    Africa molecular diagnostics market, by country, 2017 - 2021, (USD Million)

TABLE 283.    Africa molecular diagnostics market, by country, 2022 - 2028 USD Million)

TABLE 284.    Africa molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 285.    Africa molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 286.    Africa molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 287.    Africa molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 288.    Africa molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 289.    Africa molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 290.    Africa molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 291.    Africa molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 292.    Africa molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 293.    Africa molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 294.    South Africa molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 295.    South Africa molecular diagnostics market, by product, 2017 - 2021 (USD Million)

TABLE 296.    South Africa molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 297.    South Africa molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 298.    South Africa molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 299.    South Africa molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 300.    South Africa molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 301.    South Africa molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 302.    South Africa molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 303.    South Africa molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 304.    Nigeria molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 305.    Nigeria molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 306.    Nigeria molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 307.    Nigeria molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 308.    Nigeria molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 309.    Nigeria molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 310.    Nigeria molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 311.    Nigeria molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 312.    Nigeria molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 313.    Nigeria molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 314.    Morocco molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 315.    Morocco molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 316.    Morocco molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 317.    Morocco molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 318.    Morocco molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 319.    Morocco molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 320.    Morocco molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 321.    Morocco molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 322.    Morocco molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 323.    Morocco molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)

TABLE 324.    Egypt molecular diagnostics market, by product, 2017 - 2021, (USD Million)

TABLE 325.    Egypt molecular diagnostics market, by product, 2022 - 2028, (USD Million)

TABLE 326.    Egypt molecular diagnostics market, by technology, 2017 – 2021, (USD Million)

TABLE 327.    Egypt molecular diagnostics market, by technology, 2022 - 2028, (USD Million)

TABLE 328.    Egypt molecular diagnostics market, by application, 2017 - 2021, (USD Million)

TABLE 329.    Egypt molecular diagnostics market, by application, 2022 - 2028, (USD Million)

TABLE 330.    Egypt molecular diagnostics market, by infectious disease diagnostics, 2017 - 2021, (USD Million)

TABLE 331.    Egypt molecular diagnostics market, by infectious disease diagnostics, 2022 - 2028, (USD Million)

TABLE 332.    Egypt molecular diagnostics market, by end-use, 2017 - 2021, (USD Million)

TABLE 333.    Egypt molecular diagnostics market, by end-use, 2022 - 2028, (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global molecular diagnostics market, 2017 – 2028

FIG. 3    Growth potential analysis, by product

FIG. 4    Growth potential analysis, by technology

FIG. 5    Growth potential analysis, by application

FIG. 6    Growth potential analysis, by end-use

FIG. 7    Porter’s analysis

FIG. 8    Company matrix analysis, 2021

FIG. 9    PESTEL analysis

FIG. 10    Key segment trends, by product

FIG. 11    Key segment trends, by technology

FIG. 12    Key segment trends, by application

FIG. 13    Key segment trends, by end-use

FIG. 14    Key regional trends

FIG. 15    Strategy dashboard, 2021
 

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: Feb 2022
  • Companies covered: 15
  • Tables & Figures: 348
  • Countries covered: 20
  • Pages: 220

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount